Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Accueil Plan du site Courrier Portail Québec Passer directement au contenu

Bruno Giros, PhD
Photo

Researcher, Douglas Institute
Director, Schizophrenia and neurodevelopmental disorders research theme, Douglas Institute
Professor, Department of Psychiatry, McGill University
Graham Boeckh Chair in Schizophrenia, Douglas Institute
Canada Research Chair in Neurobiology of Mental Disorders


bruno_dot_giros_At_mcgill_dot_ca
Publications

2012

Bacq A., Balasse L., Biala G., Guiard B., Gardier A. M., Schinkel A., Louis F., Vialou V., Martres M. P., Chevarin C., Hamon M., Giros B., Gautron S. (2012). Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response, Mol Psychiatry, 17(9), 926-39. Find out more.

Baudin A., Blot K., Verney C., Estevez L., Santamaria J., Gressens P., Giros B., Otani S., Dauge V., Naudon L. (2012). Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex, Neurobiol Learn Mem, 98(3), 207-14. Find out more.

Berthet A., Bezard E., Porras G., Fasano S., Barroso-Chinea P., Dehay B., Martinez A., Thiolat M. L., Nosten-Bertrand M., Giros B., Baufreton J., Li Q., Bloch B., Martin-Negrier M. L. (2012). L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor, J Neurosci, 32(2), 681-91. Find out more.

El Khoury M. A., Gorgievski V., Moutsimilli L., Giros B., Tzavara E. T. (2012). Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies, Prog Neuropsychopharmacol Biol Psychiatry, 38(1), 36-50. Find out more.

Farley S., Dumas S., El Mestikawy S., Giros B. (2012). Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801, Neuropharmacology, 62(1), 503-17. Find out more.

Fournet V., Schweitzer A., Chevarin C., Deloulme J. C., Hamon M., Giros B., Andrieux A., Martres M. P. (2012). The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances, J Neurochem, 121(1), 99-114. Find out more.

Fournet V., de Lavilleon G., Schweitzer A., Giros B., Andrieux A., Martres M. P. (2012). Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice, J Neurochem, 123(6), 982-96. Find out more.

Haenisch B., Drescher E., Thiemer L., Xin H., Giros B., Gautron S., Bonisch H. (2012). Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3, Naunyn Schmiedebergs Arch Pharmacol, 385(10), 1017-23. Find out more.

<< Back to Bruno Giros 's profile
Sort by :
By year :
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008

[+] view more

The future of neuroscience research in mental health: a 2008 lecture by Bruno Giros (in French)
path
send
share
share